MedTrace Logo

Consistent CTO Trial

NCT02227771 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 215

Last updated 2017-05-18

No results posted yet for this study

Summary

The purpose of this study is to demonstrate that enhanced vascular healing with the Synergy stent should minimize the risk of late aneurysm formation and potential clinical complications but not at the cost of enhanced efficacy.

Conditions

  • Chronic Total Occlusion

Interventions

DEVICE

Percutaneous coronary intervention

Sponsors & Collaborators

  • Ceric Sàrl

    collaborator INDUSTRY

  • European Cardiovascular Research Center

    lead NETWORK

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-31
Primary Completion
2016-12-31
Completion
2018-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02227771 on ClinicalTrials.gov